Toregem BioPharma

Japan
Osaka, Osaka, Japan, 602-0841

Company profile

Toregem BioPharma company profile

Toregem BioPharma is a startup from Kyoto University that develops a treatment for congenital adentia. Toregem BioPharma is headquartered in Kyoto, Japan.

Business identity

Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2020-05-01, Month

Headquarters

Postal code
602-0841
Country code
JP
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
4
Total equity funding
$7.1M
Last funding
Series A / $2.6M / 2023-07-03
Last equity funding
Series A / $2.6M
Investors
6
Lead investors
2
Founders
3
Articles
15

Founders and investors

Founders

Honoka KisoKatsu TakahashiMuneo Takatani

Lead investors

Kyogin Lease & CapitalKyoto University Innovation Capital

Investors

Astellas Venture ManagementGemsekiKyogin Lease & CapitalKyoto University Innovation CapitalMiraidoa